MedPath

Prevention of Perioperative Acute Renal Failure

Phase 4
Terminated
Conditions
Abdominal Surgery
Interventions
Drug: Isotonic saline
Registration Number
NCT00953940
Lead Sponsor
Hospital Universitario Ramon y Cajal
Brief Summary

The purpose of this study is to measure the acute renal dysfunction on the first, second, seventh and twentieth days.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
600
Inclusion Criteria
  • All patients who are undergoing elective abdominal surgery after appropriate information of the study, and its possible risks that may arise therefrom and that at any time to refuse their cooperation, give a written consent to participate in the study.
  • Patients who at the time of the interview have an ASA between 2 and 4.
  • Patients with chronic kidney failure mild moderate (serum creatinine between 1.5 and 3.0 mg / dl) can be included.
Exclusion Criteria
  • Chronic kidney diseases with serum creatinine higher than 3.0 mg /DL
  • Laparoscopic abdominal surgery
  • ASA 1 and ASA 5 patients.
  • Patients with cardiac insufficiency, ascites and respiratory insufficiency
  • Diastolic hypertension > 100 mmHg

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Isotonic salineIsotonic salineIsotonic saline
Primary Outcome Measures
NameTimeMethod
Serum creatinine in the first, second, seventh and twenty after surgery in patients undergoing elective abdominal surgery.5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Ramon y Cajal

馃嚜馃嚫

Madrid, Spain

漏 Copyright 2025. All Rights Reserved by MedPath